Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Nov 8, 2021 (5 years ago)

Clindamycin and Benzoyl Peroxide Gel

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Superpotent Drug

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Clindamycin and Benzoyl Peroxide Gel, 1%/5% 25 g jars, Rx only, Mfg by TOLMAR Inc. Fort collins, CO 80526, NDC 0781-7263-68

Affected NDC 0781-7263-68

Compare with the code on your package — it is the most precise check available.

Drug: Clindamycin Category: Antibiotic

Recalling firm
TOLMAR, Inc.
NDC code
0781-7263-68
Origin
CO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0282-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Clindamycin recalls

See all

Other recalls by TOLMAR, Inc.

All 2021 recalls
Class II · Moderate risk

Naftifine Hydrochloride Gel

Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention Time

Terminated Impurity / degradation Tolmar, Inc. NDC 0115-1510-48 D-1300-2022